JP2023515199A5 - - Google Patents
Info
- Publication number
- JP2023515199A5 JP2023515199A5 JP2022551584A JP2022551584A JP2023515199A5 JP 2023515199 A5 JP2023515199 A5 JP 2023515199A5 JP 2022551584 A JP2022551584 A JP 2022551584A JP 2022551584 A JP2022551584 A JP 2022551584A JP 2023515199 A5 JP2023515199 A5 JP 2023515199A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- trgv9
- target
- cdr2
- cdr3
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (91)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062982574P | 2020-02-27 | 2020-02-27 | |
| US202062982478P | 2020-02-27 | 2020-02-27 | |
| US202062982664P | 2020-02-27 | 2020-02-27 | |
| US202062982469P | 2020-02-27 | 2020-02-27 | |
| US202062982374P | 2020-02-27 | 2020-02-27 | |
| US202062982669P | 2020-02-27 | 2020-02-27 | |
| US202062982525P | 2020-02-27 | 2020-02-27 | |
| US202062982505P | 2020-02-27 | 2020-02-27 | |
| US202062982462P | 2020-02-27 | 2020-02-27 | |
| US202062982591P | 2020-02-27 | 2020-02-27 | |
| US202062982602P | 2020-02-27 | 2020-02-27 | |
| US202062982535P | 2020-02-27 | 2020-02-27 | |
| US202062982492P | 2020-02-27 | 2020-02-27 | |
| US202062982548P | 2020-02-27 | 2020-02-27 | |
| US62/982,602 | 2020-02-27 | ||
| US62/982,574 | 2020-02-27 | ||
| US62/982,669 | 2020-02-27 | ||
| US62/982,525 | 2020-02-27 | ||
| US62/982,664 | 2020-02-27 | ||
| US62/982,478 | 2020-02-27 | ||
| US62/982,535 | 2020-02-27 | ||
| US62/982,374 | 2020-02-27 | ||
| US62/982,591 | 2020-02-27 | ||
| US62/982,469 | 2020-02-27 | ||
| US62/982,492 | 2020-02-27 | ||
| US62/982,505 | 2020-02-27 | ||
| US62/982,548 | 2020-02-27 | ||
| US62/982,462 | 2020-02-27 | ||
| US202062989027P | 2020-03-13 | 2020-03-13 | |
| US202062989036P | 2020-03-13 | 2020-03-13 | |
| US202062989006P | 2020-03-13 | 2020-03-13 | |
| US202062989052P | 2020-03-13 | 2020-03-13 | |
| US202062989075P | 2020-03-13 | 2020-03-13 | |
| US202062989010P | 2020-03-13 | 2020-03-13 | |
| US202062988996P | 2020-03-13 | 2020-03-13 | |
| US202062989057P | 2020-03-13 | 2020-03-13 | |
| US202062989042P | 2020-03-13 | 2020-03-13 | |
| US202062989002P | 2020-03-13 | 2020-03-13 | |
| US202062989024P | 2020-03-13 | 2020-03-13 | |
| US202062989045P | 2020-03-13 | 2020-03-13 | |
| US202062989068P | 2020-03-13 | 2020-03-13 | |
| US202062989018P | 2020-03-13 | 2020-03-13 | |
| US62/989,010 | 2020-03-13 | ||
| US62/989,027 | 2020-03-13 | ||
| US62/989,042 | 2020-03-13 | ||
| US62/989,036 | 2020-03-13 | ||
| US62/989,075 | 2020-03-13 | ||
| US62/989,006 | 2020-03-13 | ||
| US62/988,996 | 2020-03-13 | ||
| US62/989,057 | 2020-03-13 | ||
| US62/989,052 | 2020-03-13 | ||
| US62/989,002 | 2020-03-13 | ||
| US62/989,018 | 2020-03-13 | ||
| US62/989,045 | 2020-03-13 | ||
| US62/989,068 | 2020-03-13 | ||
| US62/989,024 | 2020-03-13 | ||
| PCT/US2020/031749 WO2020227457A1 (en) | 2019-05-08 | 2020-05-07 | Materials and methods for modulating t cell mediated immunity |
| USPCT/US2020/031749 | 2020-05-07 | ||
| US202063074839P | 2020-09-04 | 2020-09-04 | |
| US202063074946P | 2020-09-04 | 2020-09-04 | |
| US202063074749P | 2020-09-04 | 2020-09-04 | |
| US202063074759P | 2020-09-04 | 2020-09-04 | |
| US202063074854P | 2020-09-04 | 2020-09-04 | |
| US202063074676P | 2020-09-04 | 2020-09-04 | |
| US202063074937P | 2020-09-04 | 2020-09-04 | |
| US202063074925P | 2020-09-04 | 2020-09-04 | |
| US202063074962P | 2020-09-04 | 2020-09-04 | |
| US202063074655P | 2020-09-04 | 2020-09-04 | |
| US202063074735P | 2020-09-04 | 2020-09-04 | |
| US202063074903P | 2020-09-04 | 2020-09-04 | |
| US202063074700P | 2020-09-04 | 2020-09-04 | |
| US202063074893P | 2020-09-04 | 2020-09-04 | |
| US63/074,893 | 2020-09-04 | ||
| US63/074,925 | 2020-09-04 | ||
| US63/074,946 | 2020-09-04 | ||
| US63/074,759 | 2020-09-04 | ||
| US63/074,735 | 2020-09-04 | ||
| US63/074,903 | 2020-09-04 | ||
| US63/074,700 | 2020-09-04 | ||
| US63/074,655 | 2020-09-04 | ||
| US63/074,962 | 2020-09-04 | ||
| US63/074,749 | 2020-09-04 | ||
| US63/074,937 | 2020-09-04 | ||
| US63/074,676 | 2020-09-04 | ||
| US63/074,839 | 2020-09-04 | ||
| US63/074,854 | 2020-09-04 | ||
| US202063112462P | 2020-11-11 | 2020-11-11 | |
| US202063112475P | 2020-11-11 | 2020-11-11 | |
| US63/112,462 | 2020-11-11 | ||
| US63/112,475 | 2020-11-11 | ||
| PCT/US2021/019766 WO2021173896A1 (en) | 2020-02-27 | 2021-02-26 | Materials and methods for modulating an immune response |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023515199A JP2023515199A (ja) | 2023-04-12 |
| JP2023515199A5 true JP2023515199A5 (https=) | 2024-03-06 |
Family
ID=77492135
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022551584A Pending JP2023515199A (ja) | 2020-02-27 | 2021-02-26 | 免疫応答を調節するための材料及び方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20220306739A1 (https=) |
| JP (1) | JP2023515199A (https=) |
| KR (1) | KR20220147631A (https=) |
| CN (1) | CN115484981A (https=) |
| AU (1) | AU2021225870A1 (https=) |
| CA (1) | CA3173268A1 (https=) |
| IL (1) | IL295897A (https=) |
| MX (1) | MX2022010664A (https=) |
| TW (1) | TW202144415A (https=) |
| WO (1) | WO2021173896A1 (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10501541B2 (en) | 2015-01-27 | 2019-12-10 | Lava Therapeutics B.V. | Single domain antibodies targeting CD1d |
| AU2019344300A1 (en) | 2018-09-19 | 2021-04-22 | LAVA Therapeutics N.V. | Dual acting CD1D immunoglobulin |
| MX2021010857A (es) | 2019-03-11 | 2021-12-15 | Janssen Biotech Inc | Anticuerpos biespecificos anti-v(beta17)/anti-cd123. |
| MA55903A (fr) | 2019-05-08 | 2022-03-16 | Janssen Biotech Inc | Matières et méthodes pour moduler l'immunité médiée par les lymphocytes t |
| CN115443150A (zh) | 2019-12-17 | 2022-12-06 | 德克萨斯大学系统董事会 | 新型ddr1抗体和其用途 |
| KR20230042035A (ko) | 2020-07-08 | 2023-03-27 | 라바 테라퓨틱스 엔.브이. | Psma와 감마-델타 t 세포 수용체에 결합할 수 있는 항체 |
| WO2022056197A1 (en) | 2020-09-11 | 2022-03-17 | Janssen Biotech, Inc. | Immune targeting molecules and uses thereof |
| US20220089737A1 (en) * | 2020-09-11 | 2022-03-24 | Janssen Biotech, Inc. | Multi-specific immune targeting molecules and uses thereof |
| TW202227495A (zh) | 2020-09-11 | 2022-07-16 | 美商健生生物科技公司 | 用於調節β鏈介導之免疫的方法及組成物 |
| EP4237003A4 (en) | 2020-10-28 | 2025-07-09 | Janssen Biotech Inc | COMPOSITIONS AND METHODS FOR MODULATING GAMMA DELTA CHAIN-MEDIATED IMMUNITY |
| CN120076829A (zh) | 2022-10-18 | 2025-05-30 | 明治制果药业株式会社 | T细胞肿瘤的治疗剂 |
| AU2023411024A1 (en) * | 2022-12-23 | 2025-08-07 | The Wistar Institute Of Anatomy And Biology | Siglec 9 inhibitors and methods of use thereof for enhancing immunotherapy efficacy |
| TW202537974A (zh) * | 2023-11-15 | 2025-10-01 | 大陸商上海盛迪醫藥有限公司 | Ｔｒｇｖ９結合蛋白及其醫藥用途 |
| WO2025220690A1 (ja) * | 2024-04-17 | 2025-10-23 | Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 | Ｔ細胞腫瘍以外の悪性腫瘍患者に有効な二重特異性抗体 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002351208A1 (en) * | 2001-12-03 | 2003-06-17 | Abgenix, Inc. | Antibodies against carbonic anhydrase IX (CA IX) tumor antigen |
| EP1790664A1 (en) * | 2005-11-24 | 2007-05-30 | Ganymed Pharmaceuticals AG | Monoclonal antibodies against claudin-18 for treatment of cancer |
| JP2012505654A (ja) * | 2008-10-14 | 2012-03-08 | ヤンセン バイオテツク，インコーポレーテツド | 抗体をヒト化及び親和性成熟する方法 |
| DK3129404T3 (da) * | 2014-04-10 | 2026-04-20 | Lava Therapeutics N V | Immunglobuliner, der binder humane vgamma9vdelta2-t-cellereceptorer |
| CA3297793A1 (en) * | 2016-12-26 | 2026-03-02 | Kagoshima University | Antibody which binds to myelin oligodendrocyte glycoprotein |
| EP3743081A4 (en) * | 2018-01-23 | 2021-12-01 | New York University | SPECIFIC ANTIBODIES OF THE DELTA 1 CHAIN OF THE T-LYMPHOCYTE RECEPTOR |
| JOP20190116A1 (ar) * | 2018-05-24 | 2019-11-24 | Janssen Biotech Inc | الأجسام المضادة لتكتل التمايز 33 (cd33)، والأجسام المضادة ثنائية النوعية لتكتل التمايز 33 (cd33)/تكتل التمايز 3 (cd3) واستخداماتها |
| CA3101271A1 (en) * | 2018-05-24 | 2019-11-28 | Janssen Biotech, Inc. | Anti-cd3 antibodies and uses thereof |
| MA55903A (fr) * | 2019-05-08 | 2022-03-16 | Janssen Biotech Inc | Matières et méthodes pour moduler l'immunité médiée par les lymphocytes t |
| JP2023517660A (ja) * | 2020-03-13 | 2023-04-26 | ヤンセン バイオテツク，インコーポレーテツド | シグレック３／ｃｄ３３に結合させるための材料及び方法 |
-
2021
- 2021-02-26 AU AU2021225870A patent/AU2021225870A1/en not_active Abandoned
- 2021-02-26 WO PCT/US2021/019766 patent/WO2021173896A1/en not_active Ceased
- 2021-02-26 KR KR1020227033246A patent/KR20220147631A/ko active Pending
- 2021-02-26 CN CN202180031394.5A patent/CN115484981A/zh active Pending
- 2021-02-26 CA CA3173268A patent/CA3173268A1/en active Pending
- 2021-02-26 TW TW110107163A patent/TW202144415A/zh unknown
- 2021-02-26 US US17/186,704 patent/US20220306739A1/en active Pending
- 2021-02-26 IL IL295897A patent/IL295897A/en unknown
- 2021-02-26 JP JP2022551584A patent/JP2023515199A/ja active Pending
- 2021-02-26 MX MX2022010664A patent/MX2022010664A/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023515199A5 (https=) | ||
| IL295897A (en) | Materials and methods for modulating an immune response | |
| JP2023126852A5 (https=) | ||
| JP2019533450A5 (https=) | ||
| FI3535392T3 (fi) | Immunologisesti havaittavia solupintavariantteja käytettäväksi soluterapiassa | |
| US20220403025A1 (en) | Therapeutic uses of anti-tcr delta variable 1 antibodies | |
| JP2024506682A5 (https=) | ||
| JP2004528806A5 (https=) | ||
| EP4265643B1 (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| JP2023537534A5 (https=) | ||
| JP2025513879A5 (https=) | ||
| JP2023540796A5 (https=) | ||
| JP2025517657A5 (https=) | ||
| EP4110390A1 (en) | Materials and methods for modulating an immune response | |
| HK40102395A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40102395B (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40102396A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40103226A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40103002B (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40103002A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40097714A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40103477A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40076296A (en) | Multispecific anti-tcr delta variable 1 antibodies | |
| HK40076296B (en) | Multispecific anti-tcr delta variable 1 antibodies |